Latest Share Chat

REMOVE ADS

Angle Share News (AGL)

Angle Information

There is currently no data for AGL

REMOVE ADS

IN BRIEF: Angle highlights supportive data for DNA analysis tool

Mon, 22nd Jan 2024 18:03

Angle PLC - Surrey-based medical diagnostics provider - Announces publication of a peer-reviewed paper in a special issue of the journal - "Current Issues in Molecular Biology" Special Issue: Advanced Solutions for Cancer Therapy. Article brings together supporting evidence for the additional and complementary information that can be obtained from circulating tumour cells, demonstrating the value of a dual analyte approach for both CTCs and ctDNA (fragments of DNA released mainly by dying cells). Angle recently announced breakthrough data for real-time parallel next generation sequencing DNA analysis of both ctDNA and CTCs from a single tube of patient blood, using a pan-cancer panel run on an Illumina NGS system.

Current stock price: 17.85 pence, down 8.5% in London on Monday

12-month change: down 42%

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com